Global Point of Care CT Imaging For Respiratory Market Size To Grow At 5.2% CAGR From 2024 to 2030.

Point of Care CT Imaging For Respiratory Market (2024-2030)

As per our research report, the global Point of Care CT Imaging For Respiratory Market size is estimated to be growing at a CAGR of 5.2% from 2024 to 2030.

Point-of-care imaging enables prompt diagnosis and treatment, minimizing the need for frequent visits to healthcare facilities. The market for point-of-care CT imaging systems is anticipated to expand in the foreseeable future, driven by the rapid results these systems can deliver. A significant number of entities within the industry are actively engaged in the development and utilization of point-of-care CT imaging systems, focusing on the detection of respiratory issues to streamline disease identification. With technology progressing swiftly and collaborative efforts aimed at enhancing Computed Tomography (CT) imaging for emergency scenarios, an increase in demand is expected to persist throughout the projected timeframe.

The global market is witnessing expansion due to factors such as an increasing elderly population, a rise in the prevalence of respiratory disorders, and advancements in respiratory diagnostic systems. With health-conscious consumers and the escalating burden of diseases, especially chronic and infectious ailments, there is an anticipated upswing in the demand for respiratory disease testing, particularly at diagnostic centers. The popularity of point-of-care imaging services, owing to their ability to offer immediate diagnosis and treatment, is on the rise, consequently reducing hospital visits

Increased investments by key market players in the research and development of improved and cost-effective point-of-care CT systems are expected to augment market revenue. Clinical trial studies on point-of-care computed tomography imaging systems are underway to comprehensively assess their effectiveness and efficiency in identifying various diseases. Consequently, various research institutes and centers are deploying the necessary tools to conduct these studies. Collaborations are being forged within the industry to enhance understanding of point-of-care computed tomography imaging, supporting study groups at research institutes.

The surge in popularity of compact point-of-care CT scanners is attributed to the COVID-19 outbreak, given their capability to facilitate early diagnosis. Chest imaging played a pivotal role in the early detection of COVID-19. Enhancing the capacity to identify image alterations emerged as a critical measure to aid clinicians in the precise and prompt diagnosis of the disease. Nevertheless, various industries experienced temporary halts or operated with minimal staff due to lockdowns and other restrictions imposed by relevant regulatory bodies in response to the recent COVID-19 outbreak.

The principal factors hindering the market's expansion include pricing pressure resulting from reductions in reimbursement and financial limitations. In 2013, the US government enacted a healthcare reform package, compelling manufacturers of medical equipment to pay a substantial annual excise tax of 2.3%. In France, the Diagnosis Related Group (DRG) system consolidates all patient care expenses into a unified future payment, minimizing the significance of reimbursement considerations. The scope of goods and services eligible for reimbursement is expanded to encompass reimbursed goods and services and their corresponding tariffs (LPPR).

In the dynamic landscape of the global POC CT Imaging for Respiratory market, emerging trends involve a heightened integration of artificial intelligence applications, advancements in portable imaging technologies, and a growing emphasis on early diagnosis of respiratory conditions. These trends create opportunities for market expansion by augmenting diagnostic capabilities, broadening the application of point-of-care imaging services, and fostering innovation in the respiratory healthcare sector.

KEY MARKET INSIGHTS: 

• Based on Product Type, Full-sized Point of Care CT Scanners are highlighted in this section, as they are acknowledged to be the biggest contributor. The wide range of imaging capabilities of these sturdy equipment make them indispensable for respiratory disease diagnosis. However, during the course of the projection period, Compact Point-of-Care CT Scanners prove to be the fastest-growing subsegment. With their increasing portability and effectiveness, these agile devices are expected to see a large increase in usage.
• Based on End User, the biggest contributors among them are hospitals, which are essential centres for respiratory diagnosis. Ambulatory Surgical Centres (ASCs) are the fastest-growing subsegment, nonetheless. Point of Care CT Imaging's flexibility and agility fit in well with the changing needs of ASCs, propelling them into a field where the respiratory diagnostics industry is seeing explosive growth.
• Based on region, North America leads the way with its strong healthcare system and high disease incidence. On the other hand, Asia Pacific emerges as the region with the quickest rate of growth over the foreseeable future. Rapid adoption of Point of Care CT Imaging for Respiratory diagnostics is driven by the region's growing patient population, rising healthcare spending, and growing awareness.
• Companies playing a leading role in the global Point of Care CT Imaging for Respiratory Market profiled in this report are Xoran Technologies, LLC, CurveBeam, Carestream Health, Planmed, Siemens Healthcare GmbH, NeuroLogica Corp.

MARKET SEGMENTATION:

By Product Type:

• Compact CT scanners
• Full-sized CT scanners

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Others

By Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Request sample for this report : https://virtuemarketresearch.com/report/point-of-care-ct-imaging-for-respiratory-market/request-sample